Anti-Human SH2D1A Monoclonal Antibody (1A650) from ProteoGenix; catalogue ARO-A23411; research use only.
Know who made it. See the evidence. Buy through one marketplace.
A powerful tool for your biotech research needs.
This monoclonal antibody is specifically designed to target the SH2D1A protein, which plays a crucial role in the immune system. The SH2D1A protein is known to regulate T-cell activation and cytokine production, making it a key player in immune response and inflammation.
The Anti-Human SH2D1A Monoclonal Antibody (1A650) is a highly specific and sensitive antibody that binds to the SH2D1A protein with high affinity. This allows for accurate and reliable detection and analysis of the protein in various biological samples.
One of the main applications of this antibody is in the study of immune disorders, such as X-linked lymphoproliferative syndrome (XLP). XLP is a rare genetic disorder that affects the immune system and can lead to severe and life-threatening complications. The Anti-Human SH2D1A Monoclonal Antibody (1A650) is a valuable tool for researchers studying XLP, as it allows for the detection and characterization of SH2D1A protein levels in patients.
In addition, this antibody can also be used in various experimental settings, such as Western blotting, immunofluorescence, and flow cytometry. Its high specificity and sensitivity make it an ideal choice for these techniques, providing accurate and reliable results.
When it comes to your biotech research, accuracy and reliability are crucial. The Anti-Human SH2D1A Monoclonal Antibody (1A650) offers both, making it an essential tool for any researcher studying the immune system and related disorders.
With its and clear, concise structure, this antibody is sure to enhance your research and provide valuable insights into the role of SH2D1A in immune function. Don’t miss out on this powerful tool – order your Anti-Human SH2D1A Monoclonal Antibody (1A650) today and take your biotech research to the next level.
ProteoGenix catalogue number ARO-A23411. For research use only.
Target: SH2 domain-containing protein 1A, Duncan disease SH2-protein, Signaling lymphocytic activation molecule-associated protein, SLAM-associated protein, T-cell signal transduction molecule SAP, SH2D1A; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
